KANEKA PHARMA AMERICA, LLC

CA

Distributor of life science systems

Active 2018–2025.

Filings
35
Filed By
1
Reported In-House
—
Reported By Firms
$1,370,000

Filings

All 20252024202320222021202020192018
YearFirmPeriodAmountDoc
2025 KING & SPALDING LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Termination 		$40,000
2025 KING & SPALDING LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$30,000
2025 KING & SPALDING LLP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$30,000
2025 KING & SPALDING LLP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$40,000
2024 KING & SPALDING LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$30,000
2024 KING & SPALDING LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$30,000
2024 KING & SPALDING LLP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report 		$30,000
2024 KING & SPALDING LLP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report 		$30,000
2023 KING & SPALDING LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report 		$30,000
2023 KING & SPALDING LLP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report 		$30,000
Page 1 of 4  ·  35 filings Next
Filed By
FirmFilingsAmount
KING & SPALDING LLP 35 $1,370,000
Issue Areas
IssueActivities
Medicare/Medicaid 35

Bills Mentioned in Filings

H.R. 4055 H.R. 8999 H.R. 8999